IP Library Granted Patent US 11,724,054
Granted Patent B2
US 11,724,054 · App. 17/316,010 · Granted Aug 15, 2023

Patient interface with blowout prevention for seal-forming portion

Inventors: Matthew Eves (Sydney, AU); Rupert Christian Scheiner (Sydney, AU); Lemmy Nga (Sydney, AU); Gerard Michael Rummery (Woodford, AU)
Assignee: ResMed Pty Ltd
A61M16/0616A61M16/0066A61M16/06A61M16/0622A61M16/0633A61M16/0666A61M16/0683A61M16/0825A61M16/0069A61M16/107A61M16/109A61M16/1055A61M16/1095A61M16/16A61M2202/0225A61M2205/42A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,724,054
App. No.
17/316,010
Granted
Aug 15, 2023
Kind
B2
Abstract

One form of the present technology includes a sealing structure to seal against a user's face around the user's airways. The sealing structure includes a flap or membrane that extends inward towards the user's airways and includes a structure that prevents an inner boundary of the flap or membrane from being blown outwards (e.g., folded backwards upon itself) due to internal pressurization.

Claims (35)

1. A patient interface for sealed delivery of a flow of air at a continuously positive pressure with respect to ambient air pressure to an entrance to the patient's airways including at least entrance of a patient's nares, wherein the patient interface is configured to maintain a therapy pressure in a range of about 3 cmH 2 O to about 40 cmH 2 O above ambient air pressure in use, throughout the patient's respiratory cycle, while the patient is sleeping, to ameliorate sleep disordered breathing, the patient interface comprising:

a sealing structure to seal the patient interface against the patient's face, the sealing structure comprising:

a sealing surface configured to form a seal around a periphery of the entrance to the patient's airways, and

a loop comprising a portion of the sealing structure folded inwards of an outer perimeter of the sealing structure and attached to an interior surface of the sealing structure such that the interior surface of the sealing structure is continuous about the loop, an exterior portion of the loop that is opposite the interior surface of the sealing structure comprises a portion of the sealing surface;

a positioning and stabilising structure to maintain the sealing structure in sealing contact with an area surrounding an entrance to the patient's airways while maintaining a therapeutic pressure at the entrance to the patient's airways;

a plenum chamber pressurised at a pressure above ambient pressure in use; and

a gas washout vent configured to allow a flow of patient exhaled CO 2 to an exterior of the patient interface to minimise rebreathing of exhaled CO 2 by the patient,

wherein the loop forms a hollow interior that is in fluid communication with the pressure above ambient pressure in the plenum chamber during use.

2. The patient interface according to claim 1 , further comprising a sealing flap protruding towards an inner perimeter of the sealing structure.

3. The patient interface according to claim 2 , wherein the sealing flap is configured to form a seal against the sides of the nose above the nasal bones and adjacent the sides of the nose above the maxilla, in the depression adjacent the endocanthion of the patient.

4. The patient interface according to claim 3 , wherein the sealing flap is configured to avoid sealing against the ala.

5. The patient interface according to claim 1 , wherein the portion of the sealing surface has increased flexibility relative to a remaining portion of the loop.

6. The patient interface according to claim 1 , wherein the portion of the sealing surface comprises a thinner wall section than a remaining portion of the loop.

7. The patient interface according to claim 1 , wherein the portion of the sealing surface comprises a thicker wall section than a remaining portion of the loop.

8. The patient interface according to claim 1 , wherein the sealing surface comprises a region of reduced friction to reduce adherence with the patient's face.

9. The patient interface according to claim 8 , wherein the region of reduced friction is a frosted surface.

10. The patient interface according to claim 8 , wherein the region of reduced friction is adapted to allow the sides of the nose of the patient to slide freely against the sealing surface.

11. The patient interface according to claim 1 , wherein the sealing surface defines an area of the sealing structure adapted to contact the patient's face.

12. The patient interface according to claim 11 , wherein the portion is part of the area of the sealing structure adapted to contact the patient's face.

13. The patient interface according to claim 1 , wherein the seal is continuous.

14. The patient interface according to claim 1 , wherein the loop is located to contact or be alongside the patient's ala.

15. The patient interface according to claim 14 , wherein the loop is located so that the exterior portion of the loop is adapted to contact or be located alongside the patient's ala.

16. The patient interface according to claim 15 , wherein the exterior portion of the loop is adapted to be located substantially parallel to the patient's ala.

17. The patient interface according to claim 1 , further comprising a second loop comprising a second portion of the sealing structure folded towards the interior of the sealing structure and attached to the interior surface of the sealing structure such that the interior surface of the sealing structure is continuous about the second loop, an exterior portion of the second loop that is opposite the interior surface of the sealing structure comprises a second portion of the sealing surface.

18. The patient interface according to claim 17 , wherein the second loop forms a hollow interior that is in fluid communication with the pressure above ambient pressure in the plenum chamber during use.

19. The patient interface according to claim 17 , wherein the loop or the loop and the second loop each comprise two open ends.

20. The patient interface according to claim 17 , wherein the loop or the loop and the second loop are adapted to prevent the sealing surface from a blowout when the patient interface is internally pressurized and adjusted by the patient.

21. The patient interface according to claim 1 , further comprising:

a sealing flap protruding towards an inner perimeter of the sealing structure; and

a second loop comprising a second portion of the sealing structure folded towards the interior of the sealing structure and attached to the interior surface of the sealing structure such that the interior surface of the sealing structure is continuous about the second loop, an exterior portion of the second loop that is opposite the interior surface of the sealing structure comprises a second portion of the sealing surface,

wherein the sealing flap is configured to form a seal against the sides of the nose above the nasal bones and adjacent the sides of the nose above the maxilla, in the depression adjacent the endocanthion of the patient,

wherein the sealing flap is configured to avoid sealing against the ala,

wherein the sealing surface comprises a region of reduced friction to reduce adherence with the patient's face,

wherein the loop or the loop and the second loop each comprise a hollow interior that is adapted to be in fluid communication with the pressure above ambient pressure, and

wherein the loop or the loop and the second loop each comprise two open ends.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2021
From: EVES, MATTHEW; NGA, LEMMY; RUMMERY, GERARD MICHAEL; SCHEINER, RUPERT CHRISTIAN
To: RESMED LIMITED
Reel/Frame 056188/0702 →
CHANGE OF NAME Recorded May 10, 2021
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 056192/0971 →
Continuity (4)
Continuation 15560957
Provisional Application 62222503 · Sep 23, 2015
Provisional Application 62138009 · Mar 25, 2015
Related Publication 20210260322A1 · Aug 26, 2021